Vivek Ramaswamy’s Roivant Sells Drugmaker Televant For $7.1 Billion After Acquiring It For $45 Million From Pfizer
On Monday, Swiss healthcare firm Roche made a significant announcement, revealing its acquisition of Telavant Holdings for a substantial upfront
Read more